1. Composition for biophotonic therapy for topical application in relation to the target tissue, wherein the composition comprises a first xanthene dye and a second xanthene dye, characterized in that the first xanthene dye has an emission spectrum that overlaps by at least 1-10%, 5- 15%, 10-20%, 15-25%, 20-30%, 25-35%, 30-40%, 35-45%, 50-60%, 55-65% or 60-70% with absorption spectrum a second xanthene dye, and wherein the first and second xanthene dyes are present in the composition at a concentration of about 0.001-0.5% by weight of the composition. The composition for biophoton therapy according to claim 1, wherein the first and second xanthene dyes are selected from the group consisting of eosin Y and fluorescein； eosin Y and Bengal pink； and fluorescein and Bengal pink. 3. The biophoton therapy composition according to claim 1, wherein the first xanthene dye is eosin Y and the second xanthene dye is fluorescein, while the composition for biophoton therapy further comprises a third xanthene dye, which is pink Bengal. A composition for biophoton therapy according to claim 1, characterized in that light activation results in a cascade of energy transfer between the first and second xanthene dyes. A composition for biophoton therapy according to claim 1, characterized in that the second xanthene dye absorbs at a wavelength in the range of the visible spectrum. A composition for biophoton therapy according to claim 1, characterized in that the first xanthene dye absorbs at a wavelength between approximately 400-500 nm. The composition for biophotonic therapy according to claim 1, characterized in that the second xanthene dye absorbs at a wavelength that is1. Композиция для биофотонной терапии для местного применения в отношении целевой ткани, при этом композиция содержит первый ксантеновый краситель и второй ксантеновый краситель, отличающаяся тем, что первый ксантеновый краситель имеет спектр испускания, который перекрывается по меньшей мере на 1-10%, 5-15%, 10-20%
